Obesity Paradox and the Effect of NT-proBNP on All-Cause and Cause-Specific Mortality

IF 2.4 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Rupinder Kaur Bahniwal, Nargiza Sadr, Colleen Schinderle, Cynthia J. Avila, Julie Sill, Rehan Qayyum
{"title":"Obesity Paradox and the Effect of NT-proBNP on All-Cause and Cause-Specific Mortality","authors":"Rupinder Kaur Bahniwal,&nbsp;Nargiza Sadr,&nbsp;Colleen Schinderle,&nbsp;Cynthia J. Avila,&nbsp;Julie Sill,&nbsp;Rehan Qayyum","doi":"10.1002/clc.70044","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>In heart failure patients, obesity is associated with better outcomes as compared to normal weight, a phenomenon called the obesity paradox.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To examine if obesity modifies the relationship between NT-proBNP and all-cause and cause-specific mortality in adults without coronary artery disease or heart failure history.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We used the National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2004 and linked it with mortality through December 31, 2019. Participants &gt; 18 years were categorized into normal weight (BMI ≤ 25 kg/m<sup>2</sup>), overweight (BMI &gt; 25–29.9 kg/m<sup>2</sup>) and obese (BMI &gt; 29.9 kg/m<sup>2</sup>). NT-proBNP levels were categorized as low (&lt; 126 pg/mL) or high (≥ 126 pg/mL). Using Cox proportional hazard models, we examined effect modification by obesity using interaction, without and with adjusting for potential confounders.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 12 621 participants, 2794 (22%) died during 202 859 person-years follow-up. In adjusted models, normal-weight participants with high NT-proBNP had 2 times higher all-cause mortality risk than those with low NT-proBNP (HR = 2.05; 95%CI = 1.74, 2.41; <i>p</i> &lt; 0.001); however, this mortality risk was 27% lower in obese participants (HR interaction = 0.73; 95%CI = 0.59, 0.92; <i>p</i> = 0.008). Similarly, in normal-weight participants, the difference in other-cause mortality risk between high and low NT-proBNP participants was significant in adjusted models (HR = 2.27; 95%CI = 1.81, 2.85; <i>p</i> &lt; 0.001) and obese participants had 48% lower other-cause mortality risk between those with high and low NT-proBNP (interaction HR = 0.52; 95%CI = 0.36, 0.77; <i>p</i> = 0.001). Conversely, obesity did not modify the relationship between NT-proBNP and cardiovascular or cancer mortality.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In patients free of heart failure or coronary artery disease, obesity may be protective against mortality associated with high NT-proBNP.</p>\n </section>\n </div>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11546245/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.70044","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In heart failure patients, obesity is associated with better outcomes as compared to normal weight, a phenomenon called the obesity paradox.

Objective

To examine if obesity modifies the relationship between NT-proBNP and all-cause and cause-specific mortality in adults without coronary artery disease or heart failure history.

Methods

We used the National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2004 and linked it with mortality through December 31, 2019. Participants > 18 years were categorized into normal weight (BMI ≤ 25 kg/m2), overweight (BMI > 25–29.9 kg/m2) and obese (BMI > 29.9 kg/m2). NT-proBNP levels were categorized as low (< 126 pg/mL) or high (≥ 126 pg/mL). Using Cox proportional hazard models, we examined effect modification by obesity using interaction, without and with adjusting for potential confounders.

Results

Of the 12 621 participants, 2794 (22%) died during 202 859 person-years follow-up. In adjusted models, normal-weight participants with high NT-proBNP had 2 times higher all-cause mortality risk than those with low NT-proBNP (HR = 2.05; 95%CI = 1.74, 2.41; p < 0.001); however, this mortality risk was 27% lower in obese participants (HR interaction = 0.73; 95%CI = 0.59, 0.92; p = 0.008). Similarly, in normal-weight participants, the difference in other-cause mortality risk between high and low NT-proBNP participants was significant in adjusted models (HR = 2.27; 95%CI = 1.81, 2.85; p < 0.001) and obese participants had 48% lower other-cause mortality risk between those with high and low NT-proBNP (interaction HR = 0.52; 95%CI = 0.36, 0.77; p = 0.001). Conversely, obesity did not modify the relationship between NT-proBNP and cardiovascular or cancer mortality.

Conclusions

In patients free of heart failure or coronary artery disease, obesity may be protective against mortality associated with high NT-proBNP.

肥胖悖论与 NT-proBNP 对全因和特定原因死亡率的影响。
背景在心力衰竭患者中,肥胖与正常体重相比具有更好的预后,这种现象被称为肥胖悖论:目的:研究肥胖是否会改变无冠状动脉疾病或心衰病史的成年人的 NT-proBNP 与全因死亡率和特定原因死亡率之间的关系:我们使用了 1999 年至 2004 年的美国国家健康与营养调查(NHANES)数据,并将其与截至 2019 年 12 月 31 日的死亡率联系起来。年龄大于 18 岁的参与者被分为体重正常(BMI ≤ 25 kg/m2)、超重(BMI > 25-29.9 kg/m2)和肥胖(BMI > 29.9 kg/m2)。NT-proBNP 水平分为低水平(结果:在 12 621 名参与者中,有 2794 人(22%)在 202 859 人年的随访期间死亡。在调整后的模型中,NT-proBNP 高的正常体重参与者的全因死亡风险比 NT-proBNP 低的参与者高 2 倍(HR = 2.05;95%CI = 1.74,2.41;P 结论:对于没有心力衰竭或冠状动脉疾病的患者,肥胖可能对与高 NT-proBNP 相关的死亡率具有保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Cardiology
Clinical Cardiology 医学-心血管系统
CiteScore
5.10
自引率
3.70%
发文量
189
审稿时长
4-8 weeks
期刊介绍: Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery. The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content. The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信